EU-Approved Rapid Tests for Bovine Spongiform Encephalopathy Detect Atypical Forms: A Study for Their Sensitivities

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Meloni, Daniela ^a   Davidse, Aart ^b   Langeveld, Jan P M ^b   Varello, Katia ^a   Casalone, Cristina ^a   Corona, Cristiano ^a   Balkema Buschmann, Anne ^c   Groschup, Martin H ^c   Ingravalle, Francesco ^a   Bozzetta, Elena ^a  

^a LIGURIA E VALLE D AOSTA   (Italy)

^b WAGENINGEN UNIVERSITY   (Netherlands)

^c FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTIC METHOD; ANIMAL TISSUE; ARTICLE; BOVINE SPONGIFORM ENCEPHALOPATHY; CONTROLLED STUDY; DIAGNOSTIC KIT; DIAGNOSTIC TEST; INTERMETHOD COMPARISON; LIMIT OF DETECTION; NONHUMAN; SENSITIVITY AND SPECIFICITY;

ANIMALS; CATTLE; DIAGNOSTIC TECHNIQUES AND PROCEDURES; DIAGNOSTIC TEST APPROVAL; ENCEPHALOPATHY, BOVINE SPONGIFORM; EUROPEAN UNION; LIMIT OF DETECTION; REAGENT KITS, DIAGNOSTIC; SENSITIVITY AND SPECIFICITY;

BOS; BOVINAE;

EID: 84866274271     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0043133     Document Type: Article

References (50)

1. Bessen RA, Marsh RF, (1994) Distinct PrP properties suggest the molecular basis of strain variation in transmissible mink encephalopathy. J Virol 68: 7859-7868.
2. Biacabe AG, Laplanche JL, Ryder S, Baron T, (2004) Distinct molecular phenotypes in bovine prion diseases. EMBO Rep 5: 110-115.
3. Casalone C, Zanusso G, Acutis P, Ferrari S, Capucci L, et al. (2004) Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease. Proc Natl Acad Sci U S A 101: 3065-3070.
4. Jacobs JG, Langeveld JPM, Biacabe AG, Acutis PL, Polak MP, et al. (2007) Molecular discrimination of atypical bovine spongiform encephalopathy strains from a geographical region spanning a wide area in Europe. J Clin Microbiol 45 (6): 182-1829.
5. Wilesmith JW, Wells GA, Cranwell MP, Ryan JB, (1988) Bovine spongiform encephalopathy: epidemiological studies. Vet Rec 123: 638-644.
6. Baron T, Biacabe AG, (2006) Origin of bovine spongiform encephalopathy. Lancet 367: 297-298; author reply 298-299.
7. Brown P, Mc Shane LM, Zanusso G, Detwile L, (2006) On the question of sporadic or atypical bovine spongiform encephalopathy and Creutzfeldt-Jakob disease. Emerging Infectious Diseases 12: 1816-21.
8. Biacabe AG, Morignat E, Vulin J, Calavas D, Baron TGM, (2008) Atypical bovine spongiform encephalopathies, France, 2001-2007. Emerging Infectious Diseases 14: 298-300.
9. Comoy EE, Casalone C, Lescoutra-Etchegaray N, Zanusso G, Freire S, et al. (2008) Atypical BSE (BASE) transmitted from asymptomatic aging cattle to a primate. PLoS One 20 3 (8): e3017.
10. Ono F, Tase N, Kurosawa A, Hiyaoka A, Ohyama A, et al. (2011) Atypical L-type bovine spongiform encephalopathy (L-BSE) transmission to cynomolgus macaques, a non-human primate. Jpn J Infect Dis 64 (1): 81-4.
11. Kong Q, Zheng M, Casalone C, Qing L, Huang S, et al. (2008) Evaluation of the human transmission risk of an atypical bovine spongiform encephalopathy prion strain. J Virol 82: 3697-3701.
12. Buschmann A, Gretzschel A, Biacabe AG, Schiebel K, Corona C, et al. (2006) Atypical BSE in Germany-proof of transmissibility and biochemical characterization. Vet Microbiol 117 (2-4): 103-16.
13. European Commission Decision 98/272/CE which is related to epidemiological surveillance of spongiform encephalopathies and which modifies Decision 94/474/CE. (1998). Official Journal of the European Union L 122 p. 59.
14. European Commission Regulation (EC) No. 999/2001 of the European Parliament and of the Council of 22 May 2001 laying down rules for the prevention, control and eradication of certain transmissible spongiform encephalopathies. (1999b) Official Journal of the European Union L 147 pp 1-40.
15. Moynagh J, Schimmel H, Kramer GN, (1999) The evaluation of tests for the diagnosis of transmissible spongiform encephalopathy in bovines. Nature 400: 105-105.
16. Opinion of the Scientific Steering Committee on the field trial evaluation of the evaluation of two new rapid BSE post mortem tests. Available: http://ec.europa.eu/food/fs/sc/ssc/out316_en.pdf. (2003)
17. Wolfang P, Pavel V (2004) The field trial of seven new rapid post mortem tests for the diagnosis of bovine spongiform encephalopathy in bovines. Available: http://irmm.jrc.ec.europa.eu/activities/TSE_testing/Documents/globalreportphaseii.pdf.
18. Scientific Report of the European Food Safety Authority on the evaluation of two rapid post mortem BSE tests. EFSA Journal 48: 1-10.
19. European Commission Regulation (EC) No 956/2010 of the European Parliament and of the Council amending Annex X to Regulation (EC) No. 999/2001 of the European Parliament and of the Council as regards the list of rapid tests. Official Journal of the European Union L 279 pp 10-12. (2010).
20. Webster K, Flowers M, Cassar C, Bayliss D (2009) Determination of analytical sensitivity (detection limit) for currently approved TSE rapid tests. Available: http://www.efsa.europa.eu/de/scdocs/doc/1436.pdf.
21. Scientific Opinion of the European Food Safety Authority on the analytical sensitivity of approved TSE rapid tests. EFSA Journal 7 (12): 1436.
22. Scientific Opinion of the European Food Safety Authority on the analytical sensitivity of approved TSE rapid tests- new data for assessment of two rapid tests. EFSA Journal 8: 1591.
23. Scientific Opinion of the European Food Safety Authority on a protocol for the evaluation of new rapid BSE post mortem tests. The EFSA Journal 508 pp. 1-20.
24. Balkema-Buschmann A, Ziegler U, Mc Intyre L, Keller M, Hoffmann C, et al. (2011) Experimental challenge of cattle with German atypical bovine spongiform encephalopathy (BSE) isolates. Journal of Toxicology and Environmental Health, Part A 74: 2, 103-109.
25. Armstrong BK, White E, Saracci R (2001) In:Principle of exposure measurement in epidemiology. Oxford: Oxford University Press. 351 p.
26. Rabe-Hesketh S, Skrondal A (2008) In:Multilevel and longitudinal modelling using Stata. College Station, Texas: S. Stata Press. 562 p.
27. Szklo M, Nieto FJ (2006) Quality assurance and control. In: Epidemiology: beyond the basics. Sudbury, Massachusetts: Jones and Bartlett Publishers. 297-350 pp.
28. Altman DG (1991) In:Practical Statistics for Medical Research. London: Chapman & Hall/CRC. 611 p.
29. Fleiss JL, Levin B, Paik MC (2003) In:Statistical Methods for Rates and Proportions. New York: John Wiley & Sons. 760 p.
30. IDEXX® HerdCheck Bovine Spongiform Encephalopathy Antigen Test Kit, EIA. IDEXX Laboratories, Westbrook, ME, USA.
31. Enfer Scientific®, Newhall, Naas, County Kildare, Ireland.
32. Prionics®- Check LIA BSE Antigen Test Kit, Prionics AG, Schlieren-Zurich, Switzerland.
33. Prionics®- Check WESTERN Prionics AG, Schlieren-Zurich, Switzerland.
34. BetaPrion® BSE EIA Test Kit, AJ Roboscreen, Leipzig, Germany.
35. PrionScreen® Test, Roche Diagnostics, Mannheim, Germany.
36. TeSeE™ Purification-Detection SAP Test Kit, Bio-Rad Laboratories, Marnes-La-Coquette, France.
37. Prionics®- Check PrioSTRIP, Prionics AG, Schlieren-Zurich, Switzerland.
38. Seuberlich T, Gsponer M, Drögemüller C, Polak PM, McCutcheon S, et al. (2012) Novel prion protein in BSE-affected cattle. Switzerland Emerging Infectious Diseases 18: 1, 158-159.
39. Pirisinu L, Di Bari M, Marcon S, Vaccari G, D'Agostino C, et al. (2010) A new method for the characterization of strain-specific conformational stability of protease-sensitive and protease-resistant PrPSc. PLoS ONE 5 (9): e12723.
40. Kittelberger R, (2012) Novel prion protein in BSE-affected cattle, Switzerland. Emerg Infect Dis 18: 890-2 doi: 10.3201/eid1805.111824.
41. Dobly A, Langeveld JPM, van Keulen L, Rodeghiero C, Durand S, et al. (2010) No H- and L-type cases in Belgium in cattle diagnosed with bovine spongiform encephalopathy (1999-2008) aging seven years and older. BMC Veterinary Research 6: 26.
42. Everest SJ, Thorne L, Barnicle DA, Edwards JC, Elliott H, et al. (2006) Atypical prion protein in sheep brain collected during the British scrapie-surveillance programme. J Gen Virol 87: 471-477.
43. Gretzschel A, Buschmann A, Langeveld JPM, Groschup M, (2006) Immunological characterization of abnormal prion protein from atypical scrapie cases in sheep using a panel of monoclonal antibodies. J Gen Virol 87: 3715-3722.
44. Klingeborn M, Wik L, Simonsson M, Renstrom LH, Ottinger T, et al. (2006) Characterization of proteinase K-resistant N- and C-terminally truncated PrP in Nor98 atypical scrapie. J Gen Virol 87: 1751-1760.
45. Caughey B, Baron GS, Chesebro B, Jeffrey M, (2009) Getting a grip on prions oligomers, amyloids, and pathological membrane interactions. Annual Review of Biochemistry 78: 177-204.
46. Grassi J, Maillet S, Simon S, Morel N, (2008) Progress and limits of TSE diagnostic tools. Vet Res 39: 33.
47. Breyer J, Wemheuer WM, Wrede A, Graham C, Benestad SL, et al. (2012) Detergents modify proteinase K resistance of PrPres in different transmissible spongiform encephalopathies (TSEs). Vet. Microbiol Doi:10.1016/j.vetmic.2011.12.008.
48. Dudas S, Yang J, Graham C, Czub M, McAllister TA, et al. 2010 Molecular, biochemical and genetic characteristics of BSE in Canada. PLoS ONE 5 (5): e10638.
49. Langeveld JPM, Erkens JHF, Rammel I, Jacobs JG, Davidse A, et al. (2011) Four independent molecular prion protein parameters for discriminating new cases of C, L, and H bovine spongiform encephalopathy in cattle. Journal of Clinical Microbiology 49: 8, 3026-3028.
50. Polak MP, Zmudzinski JF, (2012) Distribution of a pathological form of prion protein in the brainstem and cerebellum in classical and atypical cases of bovine spongiform encephalopathy. The Veterinary Journal 191: 128-130.